Etomoxir-induced partial carnitine palmitoyltransferase-I (CPT-I) inhibition in vivo does not alter cardiac long-chain fatty acid uptake and oxidation rates

Biochemical Journal

Volumn 419, Issue 2, 2009, Pages 447-455

  Luiken, Joost J F P ^a   Niessen, Hanneka E C ^a   Coort, Susan L M ^a   Hoebers, Nicole ^a   Coumans, Will A ^a   Schwenk, Robert W ^a   Bonen, Arend ^b   Glatz, Jan F C ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF GUELPH   (Canada)

Author keywords

Camitine palmitoyltransferase I; CD36; Long chain fatty acid oxidation; Long chain fatty acid uptake; Mitochondria; Sarcolemmal transport

Indexed keywords

CAMITINE PALMITOYLTRANSFERASE-I; CD36; LONG-CHAIN FATTY ACID OXIDATION; LONG-CHAIN FATTY ACID UPTAKE; SARCOLEMMAL TRANSPORT;

ACIDS; BINDING SITES; CELL MEMBRANES; CHARGE TRAPPING; GLUCOSE; GLYCEROL; METABOLISM; MITOCHONDRIA; OXIDATION; RATS;

FATTY ACIDS;

CARNITINE PALMITOYLTRANSFERASE I; CD36 ANTIGEN; ETOMOXIR; FATTY ACID BINDING PROTEIN; FATTY ACID TRANSPORTER; LONG CHAIN FATTY ACID; LONG CHAIN FATTY ACID COENZYME A LIGASE; PALMITIC ACID; TRIACYLGLYCEROL; CARNITINE PALMITOYLTRANSFERASE; EPOXIDE; FATTY ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; GLUCOSE TRANSPORT; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE FIBER MEMBRANE; HEART MUSCLE OXYGEN CONSUMPTION; HOMEOSTASIS; LIPID STORAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; TISSUE LEVEL; ANIMAL; CELL CULTURE; DRUG EFFECT; ENZYME ACTIVATION; METABOLISM; OXIDATION REDUCTION REACTION; POLYACRYLAMIDE GEL ELECTROPHORESIS; TRANSPORT AT THE CELLULAR LEVEL; WESTERN BLOTTING;

RATTUS;

ANIMALS; BIOLOGICAL TRANSPORT; BLOTTING, WESTERN; CARNITINE O-PALMITOYLTRANSFERASE; CELLS, CULTURED; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME ACTIVATION; EPOXY COMPOUNDS; FATTY ACIDS; MALE; MYOCYTES, CARDIAC; OXIDATION-REDUCTION; RATS; TRIGLYCERIDES;

EID: 64249101080     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20082159     Document Type: Article

References (38)

1. Stanley, W. C., Recchia, F. A. and Lopaschuk, G. D. (2005) Myocardial substrate metabolism in the normal and failing heart. Physiol. Rev. 85, 1093-1129
2. Luiken, J. J., Turcotte, L. P. and Bonen, A. (1999) Protein-mediated palmitate uptake and expression of fatty acid transport proteins in heart giant vesicles. J. Lipid Res. 40, 1007-1016
3. Glatz, J. F., Bonen, A., Ouwens, D. M. and Luiken, J. J. (2006) Regulation of sarcolemmal transport of substrates in the healthy and diseased heart. Cardiovasc. Drugs Ther. 20, 471-476
4. Luiken, J. J., Coort, S. L., Koonen, D. P., van der Horst, D. J., Bonen, A., Zorzano, A. and Glatz, J. F. (2004) Regulation of cardiac long-chain fatty acid and glucose uptake by translocation of substrate transporters. Pflugers Arch. 448, 1-15
5. Eaton, S. (2002) Control of mitochondrial beta-oxidation flux. Prog. Lipid. Res. 41, 197-239
6. Kerner, J. and Hoppel, C. (2000) Fatty acid import into mitochondria. Biochim. Biophys. Acta 1486, 1-17
7. Weis, B. C., Cowan, A. T., Brown, N., Foster, D. W. and McGarry, J. D. (1994) Use of a selective inhibitor of liver carnitine palmitoyltransferase I (CPT I) allows quantification of its contribution to total CPT I activity in rat heart: evidence that the dominant cardiac CPT I isoform is identical to the skeletal muscle enzyme. J. Biol. Chem. 269, 26443-26448
8. Awan, M. M. and Saggerson, E. D. (1993) Malonyl-CoA metabolism in cardiac myocytes and its relevance to the control of fatty acid oxidation. Biochem. J. 295, 61-66
9. Saddik, M., Gamble, J., Witters, L. A. and Lopaschuk, G. D. (1993) Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart. J. Biol. Chem. 268, 25836-25845
10. Carley, A. N., Atkinson, L. L., Bonen, A., Harper, M. E., Kunnathu, S., Lopaschuk, G. D. and Severson, D. L. (2007) Mechanisms responsible for enhanced fatty acid utilization by perfused hearts from type 2 diabetic db/db mice. Arch. Physiol. Biochem. 113, 65-75
11. Luiken, J. J., van Nieuwenhoven, F. A., America, G., van der Vusse, G. J. and Glatz, J. F. (1997) Uptake and metabolism of palmitate by isolated cardiac myocytes from adult rats: involvement of sarcolemmal proteins. J. Lipid. Res. 38, 745-758
12. Bonen, A., Han, X. X., Habets, D. D., Febbraio, M., Glatz, J. F. and Luiken, J. J. (2007) A null mutation in skeletal muscle FAT/CD36 reveals its essential role in insulin- and AICAR-stimulated fatty acid metabolism. Am. J. Physiol. Endocrinol. Metab. 292, E1740-E1749
13. Rupp, H., Wahl, R. and Hansen, M. (1992) Influence of diet and carnitine palmitoyltransferase I inhibition on myosin and sarcoplasmic reticulum. J. Appl. Physiol. 72, 352-360
14. Schmitz, F. J., Rosen, P. and Reinauer, H. (1995) Improvement of myocardial function and metabolism in diabetic rats by the carnitine palmitoyl transferase inhibitor etomoxir. Horm. Metab. Res. 27, 515-522
15. Hayashi, K., Okumura, K., Matsui, H., Murase, K., Kamiya, H., Saburi, Y., Numaguchi, Y., Toki, Y. and Hayakawa, T. (2001) Involvement of 1,2-diacylglycerol in improvement of heart function by etomoxir in diabetic rats. Life Sci. 68, 1515-1526
16. Cabrero, A., Merlos, M., Laguna, J. C. and Carrera, M. V. (2003) Down-regulation of acyl-CoA oxidase gene expression and increased NF-κB activity in etomoxir-induced cardiac hypertrophy. J. Lipid Res. 44, 388-398
17. Campbell, S. E., Tandon, N. N., Woldegiorgis, G., Luiken, J. J., Glatz, J. F. and Bonen, A. (2004) A novel function for fatty acid translocase (FAT)/CD36: involvement in long chain fatty acid transfer into the mitochondria. J. Biol. Chem. 279, 36235-36241
18. Scholte, H. R., Jennekens, F. G. and Bouvy, J. J. (1979) Carnitine palmitoyltransferase II deficiency with normal carnitine palmitoyltransferase I in skeletal muscle and leucocytes. J. Neurol. Sci. 40, 39-51
19. Hasselbaink, D. M., Roemen, T. H. and van der Vusse, G. J. (2002) Protein acylation in the cardiac muscle like cell line, H9c2. Mol. Cell. Biochem. 239, 101-112
20. Yotsumoto, T., Naitoh, T., Kitahara, M. and Tsuruzoe, N. (2000) Effects of carnitine palmitoyltransferase I inhibitors on hepatic hypertrophy. Eur. J. Pharmacol. 398, 297-302
21. Koonen, D. P., Coumans, W. A., Arumugam, Y., Bonen, A., Glatz, J. F. and Luiken, J. J. (2002) Giant membrane vesicles as a model to study cellular substrate uptake dissected from metabolism. Mol. Cell. Biochem. 239, 121-130
22. Kammermeier, H. and Rose, H. (1988) Are isolated cardiomyocytes a suitable experimental model in all lines of investigation in basic cardiology? Basic Res. Cardiol. 83, 343-349
23. 2-exposed rats studied in isolated working heart. J. Appl. Physiol. 73, 2289-2296
24. 0-ATPase in rat and human myocardium. Biochim. Biophys. Acta 1504, 329-339
25. Randle, P. J., Garland, P. B., Newsholme, E. A. and Hales, C. N. (1965) The glucose fatty acid cycle in obesity and maturity onset diabetes mellitus. Ann. N.Y. Acad. Sci. 131, 324-333
26. Bartlett, K. and Eaton, S. (2004) Mitochondrial β-oxidation. Eur. J. Biochem. 271, 462-469
27. Westerhoff, H. V., Groen, A. K. and Wanders, R. J. (1984) Modern theories of metabolic control and their applications (review). Biosci. Rep. 4, 1-22
28. Vetter, R. and Rupp, H. (1994) CPT-1 inhibition by etomoxir has a chamber-related action on cardiac sarcoplasmic reticulum and isomyosins. Am. J. Physiol. 267, H2091-H2099
29. +-ATPase activity by etomoxir in diabetic rats. J. Appl. Physiol. 86, 812-818
30. Dhalla, N. S., Elimban, V. and Rupp, H. (1992) Paradoxical role of lipid metabolism in heart function and dysfunction. Mol. Cell. Biochem. 116, 3-9
31. Zarain-Herzberg, A. and Rupp, H. (2002) Therapeutic potential of CPT I inhibitors: cardiac gene transcription as a target. Expert Opin. Investig. Drugs. 11, 345-356
32. Stanley, W. C., Lopaschuk, G. D. and McCormack, J. G. (1997) Regulation of energy substrate metabolism in the diabetic heart. Cardiovasc. Res. 34, 25-33
33. Coort, S. L., Hasselbaink, D. M., Koonen, D. P., Willems, J., Coumans, W. A., Chabowski, A., van der Vusse, G. J., Bonen, A., Glatz, J. F. and Luiken, J. J. (2004) Enhanced sarcolemmal FAT/CD36 content and triacylglycerol storage in cardiac myocytes from obese zucker rats. Diabetes 53, 1655-1663
34. Carley, A. N. and Severson, D. L. (2005) Fatty acid metabolism is enhanced in type 2 diabetic hearts. Biochim. Biophys. Acta 1734, 112-126
35. Lopaschuk, G. D. (2006) Optimizing cardiac fatty acid and glucose metabolism as an approach to treating heart failure. Semin. Cardiothorac. Vasc. Anesth. 10, 228-230
36. Rajabi, M., Kassiotis, C., Razeghi, P. and Taegtmeyer, H. (2007) Return to the fetal gene program protects the stressed heart: a strong hypothesis. Heart Fail. Rev. 12, 331-343
37. Kampf, J. P. and Kleinfeld, A. M. (2007) Is membrane transport of FFA mediated by lipid, protein, or both? An unknown protein mediates free fatty acid transport across the adipocyte plasma membrane. Physiology (Bethesda) 22, 7-14
38. Habets, D. D., Coumans, W. A., Voshol, P. J., den Boer, M. A., Febbraio, M., Bonen, A., Glatz, J. F. and Luiken, J. J. (2007) AMPK-mediated increase in myocardial long-chain fatty acid uptake critically depends on sarcolemmal CD36. Biochem. Biophys. Res. Commun. 355, 204-210